PubMed:25888525 / 903-1091 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/25888525","sourcedb":"PubMed","sourceid":"25888525","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/25888525","text":"The trial incorporates three monthly treatment with albendazole or matching placebo for one year, whereby each treatment round consists of three consecutive days of supervised drug intake.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T8","span":{"begin":0,"end":188},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":188},"obj":"Sentence"}],"attributes":[{"subj":"T8","pred":"source","obj":"Inflammaging"},{"subj":"T8","pred":"source","obj":"Inflammaging"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#aa93ec","default":true}]}]}}